PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Seraphina Therapeutics launches Fatty15 geriatric dietary supplement

Fatty15 is the first product based on C15:0, a micronutrient recently discovered to be critical to maintaining health

Image source: PR Newswire
Image source: PR Newswire

Seraphina Therapeutics, a health company based in the US, dedicated to advancing global health through the discovery and development of essential micronutrients, has launched fatty15, the first and only dietary supplement to contain the pure fatty acid, C15:0, recently discovered to be critical to maintaining health, especially as we age. 

Years of military and academic research confirm C15:0 can guard against age-related breakdown by significantly promoting cellular resilience, enhancing mitochondrial function, and naturally activating specific receptors throughout our body that regulate immunity, metabolism, mood, sleep, and appetite.

Leading the groundbreaking studies revealing C15:0 as the first essential fatty acid to be discovered in nearly 100 years is the husband-wife duo of doctor and veterinarian, Drs Eric and Stephanie Venn-Watson. In addition to their landmark studies on C15:0 demonstrating its efficacy, numerous independent global studies have repeatedly shown higher C15:0 blood levels are linked to better health, and a large-scale study involving over 14,000 people tracked over 14 years found people who had more C15:0 in their diet had higher survival rates throughout the study period.

Seraphina Therapeutics has raised $6.2 million from top biotechnology investors as part of its Series A financing round.

Created with sustainability in mind, fatty15 sends customers a reusable, refillable glass bottle with an eco-friendly bamboo top that fits up to a 90-day supply, with refills shipped quarterly for less environmental impact.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026